Pakistani E
SENIOR MEMBER
- Joined
- May 8, 2013
- Messages
- 7,059
- Reaction score
- 27
- Country
- Location
Ministers have been urged by top doctors to reveal the extent of national drug stocks, amid growing evidence patients are stockpiling medication in preparation for a no-deal Brexit.
The Royal College of Physicians (RCP), which represents tens of thousands of doctors, urged the government to be more “transparent about national stockpiles, particularly for things that are already in short supply or need refrigeration, such as insulin”.
Prof Andrew Goddard, the RCP president, said: “Faith in the system will be created by openness and regular updates to trusts and clinicians; this will allow clinicians to reassure patients.”
Generic drugs are usually bought through nationally set tariff prices. However, pharmacies can apply for price concessions under which the NHSwill temporarily pay more when the drugs are in short supply. The number of concessions the PSNC applied for went up from 45 in October, to 72 in November and 87 in December.
The Guardian has also found evidence some patients are stockpiling drugs, against official guidance. They said they were doing so by ordering drugs from abroad, and by asking their GPs for emergency prescriptions. One diabetic patient has been stockpiling insulin for four months, ordering twice the amount he needs for each of his drugs from the pharmacist.
Robin Hewings, the head of policy at Diabetes UK, backed calls for more transparency from the government about current stock levels to reassure patients. “There is a level of concern that has risen quite a lot [in the last few months] and people with diabetes are talking about stockpiling. The government needs to be more transparent about insulin supplies."
Hewings said people with diabetes in particular needed more reassurance.
The government has asked pharmaceutical companies to stockpile medicines as part of a UK-wide, no-deal contingency plan. However, patients, GPs and hospitals have been told they do not need to bring in extra supplies.
Rachel Power, the chief executive of the Patients Association, said patients were in a very difficult position.
She said: “It is impossible to say whether the government’s contingency planning will prove adequate … the uncertainty over Brexit is leaving patients who rely on medicine for their day-to-day wellbeing on the horns of a dreadful dilemma.”
Goddard said: “The Department for Health and Social Care must work with NHS trusts and clinicians to create confidence in the new measures … During this period, we recognise the DHSC advice for hospitals, pharmacies and patients not to stockpile medicines, but urge transparency about national stockpiles, particularly for things that are already in short supply or need refrigeration, for example, insulin.”
He added: “Faith in the system will be created by openness and regular updates to trusts and clinicians; this will allow clinicians to reassure patients.”
The deputy chief executive of NHS Providers, Saffron Cordery, said: “Obviously, it’s immensely helpful to have guidance from government on how trusts should start to plan for a no-deal Brexit … A real concern is that clearly this guidance comes at a time when trusts are having to prioritise responding to the pressures of winter.”
A DHSC spokesperson said: “We have not seen any evidence of current medicine supply issues linked to EU exit preparations … Patients should not stockpile … the supply of medicines will be uninterrupted in the event of exiting the EU without a deal.”
https://www.theguardian.com/politic...nts-stockpile-drugs-in-fear-of-no-deal-brexit
The Royal College of Physicians (RCP), which represents tens of thousands of doctors, urged the government to be more “transparent about national stockpiles, particularly for things that are already in short supply or need refrigeration, such as insulin”.
Prof Andrew Goddard, the RCP president, said: “Faith in the system will be created by openness and regular updates to trusts and clinicians; this will allow clinicians to reassure patients.”
Generic drugs are usually bought through nationally set tariff prices. However, pharmacies can apply for price concessions under which the NHSwill temporarily pay more when the drugs are in short supply. The number of concessions the PSNC applied for went up from 45 in October, to 72 in November and 87 in December.
The Guardian has also found evidence some patients are stockpiling drugs, against official guidance. They said they were doing so by ordering drugs from abroad, and by asking their GPs for emergency prescriptions. One diabetic patient has been stockpiling insulin for four months, ordering twice the amount he needs for each of his drugs from the pharmacist.
Robin Hewings, the head of policy at Diabetes UK, backed calls for more transparency from the government about current stock levels to reassure patients. “There is a level of concern that has risen quite a lot [in the last few months] and people with diabetes are talking about stockpiling. The government needs to be more transparent about insulin supplies."
Hewings said people with diabetes in particular needed more reassurance.
The government has asked pharmaceutical companies to stockpile medicines as part of a UK-wide, no-deal contingency plan. However, patients, GPs and hospitals have been told they do not need to bring in extra supplies.
Rachel Power, the chief executive of the Patients Association, said patients were in a very difficult position.
She said: “It is impossible to say whether the government’s contingency planning will prove adequate … the uncertainty over Brexit is leaving patients who rely on medicine for their day-to-day wellbeing on the horns of a dreadful dilemma.”
Goddard said: “The Department for Health and Social Care must work with NHS trusts and clinicians to create confidence in the new measures … During this period, we recognise the DHSC advice for hospitals, pharmacies and patients not to stockpile medicines, but urge transparency about national stockpiles, particularly for things that are already in short supply or need refrigeration, for example, insulin.”
He added: “Faith in the system will be created by openness and regular updates to trusts and clinicians; this will allow clinicians to reassure patients.”
The deputy chief executive of NHS Providers, Saffron Cordery, said: “Obviously, it’s immensely helpful to have guidance from government on how trusts should start to plan for a no-deal Brexit … A real concern is that clearly this guidance comes at a time when trusts are having to prioritise responding to the pressures of winter.”
A DHSC spokesperson said: “We have not seen any evidence of current medicine supply issues linked to EU exit preparations … Patients should not stockpile … the supply of medicines will be uninterrupted in the event of exiting the EU without a deal.”
https://www.theguardian.com/politic...nts-stockpile-drugs-in-fear-of-no-deal-brexit